Mr. Basham brings over 40 years of experience in the US medical device industry building products and companies. He has served on company boards and/or held C-level positions of many companies including Oasis Biosciences which was acquired by Genprobe, Affinergy, Chesson Labs, and Colmed which was acquired by Cooper Industries. Mr. Basham led the formation of a series of companies around discrete technologies that collectively became Closure Medical which was acquired by J&J.  Mr. Basham led the growth of the CDMO, Metrics, Inc which was sold to Mayne Pharma.  More recently, Mr. Basham founded RFPi (now Perfusio) and successfully led the company to the FDA approval and out-licensing of its core first product. Mr Basham received his MBA from Keller Graduate School of Management.